 Bragar Eagel Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Pfenex Inc. NYSE: PFNX breached their fiduciary duties or violated the federal securities laws in connection with the companys merger with Ligand Pharmaceuticals Inc. NASDAQ: LGND. 